These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 946336

  • 21. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L, Baggio GF, Bergamasco B, Barile C, Cocito D, Delsedime M, Perla F, Riccio A, Bergamini L.
    Acta Neurol (Napoli); 1985; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Intrathecal methylprednisolone acetate in multiple sclerosis treatment: effect on the blood-CSF barrier and on the intrathecal IgG production.
    Rocchelli B, Poloni M, Mazzarello P, Piccolo G, Delodovici M, Pinelli P.
    Ital J Neurol Sci; 1982 Jul; 3(2):119-26. PubMed ID: 6896866
    [No Abstract] [Full Text] [Related]

  • 24. The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis.
    Dalton CM, Keenan E, Jarrett L, Buckley L, Stevenson VL.
    Mult Scler; 2008 May; 14(4):571-2. PubMed ID: 18562512
    [Abstract] [Full Text] [Related]

  • 25. Complications from intrathecal steroid therapy in patients wsith multiple sclerosis.
    Nelson DA, Vates TS, Thomas RB.
    Acta Neurol Scand; 1973 May; 49(2):176-88. PubMed ID: 4740461
    [No Abstract] [Full Text] [Related]

  • 26. [Treatment of optic neuritis with corticosteroids. Discussion at the 10th Meeting of the International Neuro-ophthalmological Society (Freiburg 5 to 9 June 1994)].
    Kommerell G.
    Klin Monbl Augenheilkd; 1994 Sep; 205(3):126-7. PubMed ID: 7996815
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms.
    Hellwig K, Stein FJ, Przuntek H, Müller T.
    BMC Neurol; 2004 Nov 07; 4(1):18. PubMed ID: 15530171
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse.
    Mirowska-Guzel DM, Kurowska K, Skierski J, Koronkiewicz M, Wicha W, Kruszewska J, Czlonkowski A, Czlonkowska A.
    J Neuroimmunol; 2006 Jul 07; 176(1-2):134-40. PubMed ID: 16723156
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The need for functional rehabilitation in multiple sclerosis.
    Boines GJ.
    Del Med J; 1970 May 07; 42(5):121-3. PubMed ID: 5468594
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS.
    Uttner I, Müller S, Zinser C, Maier M, Süssmuth S, Claus A, Ostermann B, Elitok E, Ecker D, Brettschneider J, Gold R, Tumani H.
    Neurology; 2005 Jun 14; 64(11):1971-3. PubMed ID: 15955958
    [Abstract] [Full Text] [Related]

  • 37. [Prospective evaluation of the effectiveness of high doses of methylprednisolone in multiple sclerosis].
    Wajgt A, Szczechowski L, Marczewska E, Grechuta M, Strzyzewska L, Gadomska B, Szyrocka-Szwed K.
    Neurol Neurochir Pol; 1988 Jun 14; 22(3):188-94. PubMed ID: 3065667
    [Abstract] [Full Text] [Related]

  • 38. [Comments on the contribution, "Immunomodulating staged therapy of multiple sclerosis by the Multiple Sclerosis Therapy Consensus Group"].
    Störh M.
    Nervenarzt; 2002 Dec 14; 73(12):1207; author reply 1207. PubMed ID: 12599336
    [No Abstract] [Full Text] [Related]

  • 39. Incidence of seizures in patients with multiple sclerosis treated with intrathecal baclofen.
    Schuele SU, Kellinghaus C, Shook SJ, Boulis N, Bethoux FA, Loddenkemper T.
    Neurology; 2005 Mar 22; 64(6):1086-7. PubMed ID: 15781838
    [Abstract] [Full Text] [Related]

  • 40. Eye movement quantitative evaluation before and after high-dose 6-methylprednisolone in multiple sclerosis.
    Versino M, Bergamaschi R, Callieco R, Romani A, Castelnovo G, Beltrami G, Cosi V.
    Acta Neurol Scand; 1994 Feb 22; 89(2):105-10. PubMed ID: 8191872
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.